Fundz

Vernal Biosciences Raises $21 Million To Accelerate Mrna Manufacturing Growth

PRIVATEJun 02, 2022

Amount Raised

$21 Million

Round Type

Funding Round

ColchesterBiotechnology

Description

Vernal Biosciences, a technology-leading mRNA manufacturer and formulator of LNP-mRNA, announced today the completion of a $21 million financing to fully integrate its mRNA manufacturing solutions. The round was led by Ampersand Capital Partners and Dynamk Capital, with existing investors Alloy Therapeutics and ATUM participating. The round also included a new investment from Charles River Laboratories, Inc. Vernal offers a complete range of mRNA-related services and products ranging from sequence design and screening support, scaled-down and scaled-up manufacturing of high purity mRNA and LNP-mRNA, platform process development technologies, and ultimately GMP manufacturing.

Quick answer

Vernal Biosciences, Inc. raised $21 Million in a Funding Round round, dated June 2, 2022. Vernal Biosciences, Inc. is based in Colchester, England, United Kingdom.

How much did Vernal Biosciences, Inc. raise?
Vernal Biosciences, Inc. raised $21 Million in a Funding Round round on June 2, 2022.
What does Vernal Biosciences, Inc. do?
Vernal Biosciences is a CDMO democratizing the use of mRNA through a quality-first approach to manufacturing mRNA for all purposes.
Where is Vernal Biosciences, Inc. based and how big is it?
Vernal Biosciences, Inc. is based in Colchester, England, United Kingdom.
Who are the decision-makers at Vernal Biosciences, Inc?
Fundz holds 1 contact at Vernal Biosciences, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Vernal Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Enko Chem raised $80M on July 15, 2022.
  • BIOVIE INC. raised $6M on July 15, 2022.
  • Gossamer Bio raised $120M on July 15, 2022.
  • MatriSys Bioscience raised $8.4M on July 15, 2022.
  • Entero Therapeutics raised $300K (Seed) on July 15, 2022.
  • PMGC Holdings Inc. raised $2.1M (Seed) on July 15, 2022.

Who to call at Vernal Biosciences, Inc., and when

A new round usually means Vernal Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vernal Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vernal Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vernal Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vernal Biosciences, Inc.

Location

261 Mountain View Drive

Colchester, England, United Kingdom

About

Vernal Biosciences is a CDMO democratizing the use of mRNA through a quality-first approach to manufacturing mRNA for all purposes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vernal Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsChristian C., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vernal Biosciences, Inc.'s next move

See what Strategic adds

Vernal Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.